Defect Prompts Mylan to Recall Some EpiPens
Rare cases of 'failure to activate' during potentially fatal allergic reactions spurred the action, company says
By E. J. Mundell
Thursday, April 6, 2017
MONDAY, April 3, 2017 (HealthDay News) -- Mylan, the maker of the EpiPen, says it is recalling "select lots" of the device used to treat dangerous allergic reactions due to a defect that might render it "difficult to activate in an emergency."
The pen-like device is used to help counteract potentially fatal reactions (anaphylactic shock) in people with severe allergies. EpiPen gives users an injection of epinephrine to help curb the reaction.
https://medlineplus.gov/news/fullstory_164432.html